Skip to content

Evaluation of the effect of Diaphragmatic Breathing on clinical and functional outcomes in children and adolescents with Asthma: a randomized controlled trial

Evaluation of the effect of Breathing Diaphragmatic in the autonomic balance and in the other functional and clinical outcomes in children and adolescents with chronic asthma: a randomized clinical trial and controlled

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3x8py3n
Enrollment
Unknown
Registered
2023-05-02
Start date
2021-07-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. The randomization list of participants will be generated by an online program (www.random.org). The blind allocation will be carr
2nd moment, after 4 weeks of the beginning of the intervention
3rd moment, after 8 weeks, at the end of the intervention. 50 patients will be included in the trial. 25 intervention group will perform diaphragmatic breathing. This is a breathing exercise in which
Place your hands on your abdomen near your navel Inhale through your nose slowly and deeply, expanding your abdomen that can be felt by your hands
pause for 2 to 3 seconds. Exhale slowly through your mouth, completely emptying your abdomen. The teaching and training of the diaphragmatic breathing technique will be given by a duly trained health
E02.190.525.186

Sponsors

Programa de Pós-graduação em Ciências da Saúde
Lead Sponsor
Programa de Pós-graduação em Ciências da Saúde
Collaborator

Eligibility

Age
7 Years to 18 Years

Inclusion criteria

Inclusion criteria: partially controlled asthma; uncontrolled asthma

Exclusion criteria

Exclusion criteria: bronchopulmonary dysplasia; cystic fibrosis; congenital cardiopulmonary diseases; immunodeficiency; chronic encephalopathy; psychomotor deficiencies

Design outcomes

Primary

MeasureTime frame
The main primary outcome of the study will be asthma control, determined through a validated questionnaire - the Asthma Control Test (ACT) ;Assess anxiety levels. Anxiety symptoms in children and adolescents will be assessed using the Spence Children's Anxiety Scale -SCAS. ;Assess basal cortisol levels by quantifying cortisol levels in salivary samples.;The severity of the airflow obstruction will be evaluated through the peak flow test, which will provide us with the forced expiratory volume.;Autonomic modulation will be evaluated through analysis of heart rate variability (HRV). Low frequency (LF = 0.04 to 0.15 Hz) and high frequency (HF = 0.15 to 0.40 Hz) spectral components expressed in normalized units (nu) are used, as well as the LF/ HF in milliseconds squared (ms²). The autonomic balance will be assessed by analyzing the HRV collected through the blood volume pulse (BVP) collected at rest and in the lying position during breathing exercise.

Secondary

MeasureTime frame
Decreased use of medication, this outcome will be evaluated through the record of clinical conduct.

Countries

Brazil

Contacts

Public ContactSara Fernandes

Universidade Federal do Rio Grande, FURG

sara.s.fernandes@hotmail.com+55 (53) 32374621

Outcome results

None listed

Source: REBEC (via WHO ICTRP)